Fetoscopic Neural Tube Defect Repair

Last updated: April 20, 2025
Sponsor: Oregon Health and Science University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Holoprosencephaly

Treatment

Fetoscopic Neural Tube Defect Repair Devices

Clinical Study ID

NCT06946563
OHSU IRB 24397
  • Ages > 18
  • Female

Study Summary

This is a single-arm prospective study to record maternal and neonatal outcomes on subjects who undergo fetoscopic repair of Neural Tube Defects (NTD) at Oregon Health & Science University (OHSU). Fetoscopic repair will take place between 24 weeks 0 days and 27 weeks 6 days gestation. Surgical, post-operative, delivery, and neonatal outcomes will be collected.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Maternal age 18 years or older

  • Capable of consenting for their own participation in the study

  • Decision to have fetoscopic repair following counseling of all options

  • Open spina bifida with the upper boundary between T1 and S1

  • Gestational age between 24 0/7 to 26 6/7 weeks' gestation at the time of surgery

  • Normal karyotype and/or normal chromosomal microarray by invasive testing. In thecase of a microdeletion, microduplication, or variant of uncertain significant, thedecision to include or exclude will be at the discretion of the PrincipalInvestigators.

  • Absence of major cardiac anomalies confirmed by fetal echocardiogram

  • Adequate social support throughout pregnancy

  • Parental or guardian willingness to undergo follow-up evaluations of the child afterbirth

Exclusion

Exclusion Criteria:

  • Multiple gestation

  • Major fetal anomalies unrelated to the neural tube defect

  • Kyphosis in fetus of 30 degrees or more as assessed by ultrasound or MRI

  • Previous spontaneous singleton preterm birth prior to 37 weeks

  • Presence of cervical cerclage at the time of surgery or history of cervicalinsufficiency

  • Cervical length less than 20 mm by endovaginal ultrasound

  • Placenta previa or evidence of placental abruption

  • Technical factors such as large uterine fibroids, uterine anomalies, or fetalmembrane separation for which the risks of surgery are deemed to outweigh thebenefits

  • Maternal obesity precluding surgical access with a BMI > 45 or if the PrincipalInvestigator determines the body habitus to be technically challenging

  • Alloimmunization in pregnancy including Kell sensitization or a history of neonatalalloimmune thrombocytopenia

  • Maternal HIV or Hepatitis B positive status. If the patient's HIV or Hepatitis Bstatus is unknown, the patient must be tested and found to be negative prior tosurgery

  • Known Hepatitis C positivity. If the patient's Hepatitis C status is known, they donot need to be screened

  • Maternal medical condition which is a contraindication to surgery or generalanesthesia. This includes previous hysterotomy in the active segment of the uterus

  • Maternal medical co-morbidities which would significantly increase the risk ofspontaneous or iatrogenic preterm delivery

  • Inability of the patient to comply with travel and follow-up requirements of thestudy

  • Patient not meeting psychosocial criteria determined by fetal care social worked tocomply with the medical care and plan for follow ups

  • Participation in another interventional study that influences maternal and fetalmorbidity and mortality

  • Known history of hypersensitivity to collagen products or chondroitin materials

Study Design

Total Participants: 25
Treatment Group(s): 1
Primary Treatment: Fetoscopic Neural Tube Defect Repair Devices
Phase:
Study Start date:
April 01, 2023
Estimated Completion Date:
April 30, 2033

Study Description

Patients undergoing fetoscopic NTD repair will be enrolled. Possible surgical approaches include completely percutaneous, laparotomy assisted, or mini laparotomy. Surgical approach will be determined by placental location, maternal body habitus, and shared decision making with the patient. The actual fetoscopic NTD repair is the same regardless of the surgical approach. Follow-up data collection will occur post-operatively, at delivery, NICU admission, and throughout childhood.

Connect with a study center

  • Oregon Health & Science University

    Portland, Oregon 97239
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.